Discovery Against All Odds

Watch Nobel Laureate Rita Levi-Montalcini tell the story of how she continued her transformative cell biology research as World War II raged.

The Scientist

| 1 min read

Listen with Speechify

0:00

1:00

Read the full story.

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!

Join for free today

Already a member? Login Here

Keywords

March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue

Research Resources

Become a PCR Pro

Learn how mastering the ins and outs of PCR can accelerate workflows and improve data.

3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Molecular detection technologies help scientists rapidly and reliably find and address ever-evolving pathogens with optimal accuracy and sensitivity.

A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

Discover the key features to consider when selecting a new refrigerator or freezer

The Immunology of the Brain

In this webinar, Kevin J. Tracey and Lawrence Steinman will discuss how researchers study the immunology of the brain and its roles in health and disease.

Products

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit

Zymo Research Corp., a leader in biotechnology and microbiome research solutions, proudly announces the launch of its new Quick-16S™ Full-Length Library Prep Kit.

BIOVECTRA is Honored with 2025 CDMO Leadership Award for Biologics

Industry Recognizes BIOVECTRA’s Excellence in Microbial Fermentation, Recombinant Protein Production, and Aseptic Fill-Finish Capabilities

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Slow temperature recovery can threaten the integrity of your work. That’s Stirling Ultracold designed the VAULT100™ to operate at setpoints down to -100°C, so your samples may never be exposed to temperatures above -70°C during a typical door opening.

We’ve updated our Privacy Policy to make it clearer how we use your personal data.

Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.

Discovery Against All Odds

The Scientist ARCHIVES

Become a Member of

Keywords

Related Research Resources

How Do Embryos Know How Fast to Develop

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks